Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. is a blank check company formed to identify and complete an initial business combination through a merger, share exchange, asset acquisition, share purchase, reorganization or similar transaction. It offers a public acquisition vehicle and related capital-raising capabilities, including units comprising Class A ordinary shares and warrants, trust-account financing and shareholder redemption mechanisms. The company evaluates prospective targets primarily within technology, hospitality and consumer services and applies defined acquisition criteria and due diligence processes. It conducts transactions through U.S. capital markets and Nasdaq-listed mechanisms, targeting businesses that would benefit from becoming public.
Summary from filing dated 2025-04-02
Frequently asked questions
What is Semnur Pharmaceuticals, Inc.'s CIK number?
Semnur Pharmaceuticals, Inc.'s SEC CIK number is 0001913577 (1913577). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Semnur Pharmaceuticals, Inc.'s SEC filings?
All of Semnur Pharmaceuticals, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.